Title: lecture il2
1(No Transcript)
2BIOMATERIALS are defined as Any
pharmacologically inert material that is used to
direct, supplement or replace the functions of
living tissue.
3BIOMATERIALS are defined as Any
pharmacologically inert material that is used to
direct, supplement or replace the functions of
living tissue.
4?
Bone cement containing antibiotics
IUDs
DDSs
BDG Polymers
Biofunctional materials
5BIOMATERIAL A material that is used in the
treatment of patients, that comes in contact
with living tissue for a significant period of
time, so that the interactions developed between
the material and the tissue are a key part of
the treatment.
6BIOMATERIAL Natural or synthetic materials that
come in contact with physiologic fluids or living
tissues, excluding the epidermis, for
prosthetic, therapeutic, directing or storage
purposes, where any pharmacologic activity
related to it, is secondary and not its main
objective.
7TYPES OF BIOMATERIALS
METALS
CERAMICS
CARBONS
NATURAL TISSUES
COMPOSITE MATERIALS
POLYMERS
8COMPOSITE MATERIALS
Different materials
Different materials of the same family
Classic Composite Materials
9TYPES OF BIOMATERIALS
METALS
CERAMICS
CARBONS
NATURAL TISSUES
COMPOSITE MATERIALS
POLYMERS
10???????
1 ??????????????? 2 ?????? ?????
????? 3 ??????????? 4 ??? ??????? 5
?????? ?????
???????
1 ??????? ???? 2 ???????????? 3
?????????? . . . 4 ??????
11POLYMERS
ELASTOMERS
PLASTICS
FIBERS
12Percutaneous devices - Implanted devices
- Extra-corporeal devices - Load-bearing implants
- Implants as part of organs - Implants for soft
tissue - Various -
Catheters
Pacemakers
Blood oxygenators
Hip prostheses
Heart valves
Artificial blood vessels
Sutures, contact lenses, IOLs, DDSs,
13Biomaterials and the devices made from them,
occupy an increasingly important role in modern
clinical medicine.
14Already back in 1988, in the United States
alone, an estimated 11 million persons had at
least one medical device implanted!!
2,5 million of these had lens implants, 1,3
million had artificial joints, 460,000 had
pacemakers, 253,000 had artificial heart
valves,
15?
REQUIREMENTS!!
(1) Has the required initial properties (chemical
physical, biological, )
(2) Retains its properties in vivo or changes
them as programmed (one hour, month, year, )
(3) Easy cleaned, manufactured and sterilized
(4) Does not cause any negative reactions in the
host (blood coagulation, hemolysis,
inflammatory response, immunogenecity,
carcinogenicity, ... )
16THE GOAL OF THE COURSE IS
NOT
17The Biomaterials Yellow Pages !!!!!
NOT
18THE GOAL FO THE COURSE IS
To present and discuss the phenomena presently
considered to play a key role in determining the
Biological Performance of the Biomaterial/Implant
.
19Introduction History, definitions,
The polymers themselves
Biological Performance
The interface
Nanosized biomaterials
Tissue Engineering
20(No Transcript)
21(No Transcript)
22Their molecular weight is high.
- Polymeric compounds exhibit a number of unique
features
They consist of repeating units (mers).
Polymers are usually polydisperse.
23OLIGOMERS (oligo few) MW lt 1500 DP lt 10
TELOMER (teleos end) A monomer unit at the end
of a polymer molecule
24POLYMERS
LOW MW(av) 1,500 5,000 DP 20 100 Chain
length lt 500 A
MEDIUM MW(av) lt 10,000 DP lt 1,000 Chain length lt
2500 A
25POLYMERS
HIGH MW(av) gt 10,000 DP gt 1,000 Chain length gt
2500 A
26MOLECULAR WEIGHT
MT
27Properties versus molecular weight
28MOLECULAR WEIGHT
MW W/N
W Total sample weight N Number of moles in
the sample
29DIFFERENT CHAIN LENGTHS ! ! !
AVERAGE MOLECULAR WEIGHT
MOLECULAR WEIGHT DISTRIBUTION
30DEGREE OF POLYMERIZATION DP
The number of repeating units in the molecule
___ __ MW DP x MWmer
31NUMBER-AVERAGE MW
- Number of molecules Xi MWi A given molecular
weight
32WEIGHT-AVERAGE MW
- Weight fraction Wi MWi - A given molecular
weight
33POLYDISPERSITY
Mw / Mn
- Breadth of distribution.
- 1 monodisperse, 2 good
- 5-10 common, 10 commercial
34 and what about the Molecular Weight
Distribution??
35MW determination
Absolute methods
Relative methods
36ABSOLUTE METHODS The quantity measured is
theoretically related to the average molecular
weight.
RELATIVE METHODS The quantity measured is in
someway related to the molecular weight, but the
exact relation must be established by calibration
with one (or more) of the absolute methods.
37 38We end up with different kinds of molecular
weight averages, depending on the way in which we
obtained the data.
39Synthetic route
Chemical nature
End use
POLYMERS
Mechanical properties
Structure
Physical state
Thermal behavior
40Synthetic route
Chemical nature
End use
POLYMERS
Mechanical properties
Structure
Physical state
Thermal behavior
41The two main polymerization mechanisms are
ADDITION
CONDENSATION
42CH2 CHX
43CH2 CHX
-Phenyl
-Cl
-H
-CONH2
-COOH
-CH3
-F
-COOMe
-OH
44Tacticity of Polymers
PP
- Isotactic
- Syndiotactic
- Atactic
45The two main polymerization mechanisms are
ADDITION
CONDENSATION
46R-OH
R-CO-OH
R-CO-OR
47HO-R-OH
HO-OC-R-CO-OH
HOOC-R-COO-R-OH
-R-O-OC-R-CO-O-R-O-COR-
48HO-CH2-CH2-OH
HO-OC-CH2-CH2-CH2-CH2-CO-OH
49Synthetic route
Chemical nature
End use
POLYMERS
Mechanical properties
Structure
Physical state
Thermal behavior
50ELEMENTS
F
Si
FUNCTIONAL GROUPS
Acrylics
Polyolefins
Polyesters
Polyamides
Polyurethanes
Polycarbonates
51Synthetic route
Chemical nature
End use
POLYMERS
Mechanical properties
Structure
Physical state
Thermal behavior
52LINEAR
53BRANCHED
54CROSS-LINKED
55Synthetic route
Chemical nature
End use
POLYMERS
Mechanical properties
Structure
Physical state
Thermal behavior
56LINEAR
THERMOPLAST
57THERMOSET
CROSS-LINKED
58BRANCHED
THERMOSET
59THERMOPLAST
BRANCHED
60BRANCHED
THERMOPLAST
61?
The two main polymerization mechanisms are
ADDITION
THERMOSET
CONDENSATION
62THERMOSET
ADDITION
AT LEAST, TWO DOUBLE BONDS!!
63THERMOSET
CONDENSATION
64Synthetic route
Chemical nature
End use
POLYMERS
Mechanical properties
Structure
Physical state
Thermal behavior
65Tg
Not OrdEReD
AMORPHOUS
CRYSTALLINE
ORDERED
Tm
66Synthetic route
Chemical nature
End use
POLYMERS
Mechanical properties
Structure
Physical state
Thermal behavior
67POLYMERS
ELASTOMERS
PLASTICS
FIBERS
68STRENGTH
STIFFNESS
ELONGATION AT BREAK
TOUGHNESS
69Synthetic route
Chemical nature
End use
POLYMERS
Mechanical properties
Structure
Physical state
Thermal behavior
70ADDITIVES
BLENDS
IPNs
COPOLYMERS
71Interpenetrating
Polymeric
Network
We start from already crosslinked P1
We also have M2, I, Xler (?) and solvent (?)
72COPOLYMERS
RANDOM
AABABBBAABBABBABABBABBA
ALTERNATE
ABABABABABABABABABABABAB
BLOCK
AAAAAABBBBBBBAAAAABBBBBB
GRAFT
73WHATS THE FUNDAMENTAL DIFFERENCE BETWEEN
BLENDS, IPNs AND COPOLYMERS ????!!???
74(No Transcript)
75(No Transcript)
76Falta MW y Tg y Tm
77FALTA SUSITA!!
78(No Transcript)
79(No Transcript)
80(No Transcript)